These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 37737636)
1. Assembling the anaerobic gamma-butyrobetaine to TMA metabolic pathway in Dwidar M; Buffa JA; Wang Z; Santos A; Tittle AN; Fu X; Hajjar AM; DiDonato JA; Hazen SL mBio; 2023 Oct; 14(5):e0093723. PubMed ID: 37737636 [TBL] [Abstract][Full Text] [Related]
2. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans. Koeth RA; Lam-Galvez BR; Kirsop J; Wang Z; Levison BS; Gu X; Copeland MF; Bartlett D; Cody DB; Dai HJ; Culley MK; Li XS; Fu X; Wu Y; Li L; DiDonato JA; Tang WHW; Garcia-Garcia JC; Hazen SL J Clin Invest; 2019 Jan; 129(1):373-387. PubMed ID: 30530985 [TBL] [Abstract][Full Text] [Related]
3. The microbial gbu gene cluster links cardiovascular disease risk associated with red meat consumption to microbiota L-carnitine catabolism. Buffa JA; Romano KA; Copeland MF; Cody DB; Zhu W; Galvez R; Fu X; Ward K; Ferrell M; Dai HJ; Skye S; Hu P; Li L; Parlov M; McMillan A; Wei X; Nemet I; Koeth RA; Li XS; Wang Z; Sangwan N; Hajjar AM; Dwidar M; Weeks TL; Bergeron N; Krauss RM; Tang WHW; Rey FE; DiDonato JA; Gogonea V; Gerberick GF; Garcia-Garcia JC; Hazen SL Nat Microbiol; 2022 Jan; 7(1):73-86. PubMed ID: 34949826 [TBL] [Abstract][Full Text] [Related]
4. Elucidation of an anaerobic pathway for metabolism of l-carnitine-derived γ-butyrobetaine to trimethylamine in human gut bacteria. Rajakovich LJ; Fu B; Bollenbach M; Balskus EP Proc Natl Acad Sci U S A; 2021 Aug; 118(32):. PubMed ID: 34362844 [TBL] [Abstract][Full Text] [Related]
5. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Koeth RA; Levison BS; Culley MK; Buffa JA; Wang Z; Gregory JC; Org E; Wu Y; Li L; Smith JD; Tang WHW; DiDonato JA; Lusis AJ; Hazen SL Cell Metab; 2014 Nov; 20(5):799-812. PubMed ID: 25440057 [TBL] [Abstract][Full Text] [Related]
6. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation. Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199 [TBL] [Abstract][Full Text] [Related]
7. The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of TMA production from choline, L-carnitine and related precursors by the human gut microbiota. Day-Walsh P; Shehata E; Saha S; Savva GM; Nemeckova B; Speranza J; Kellingray L; Narbad A; Kroon PA Eur J Nutr; 2021 Oct; 60(7):3987-3999. PubMed ID: 33934200 [TBL] [Abstract][Full Text] [Related]
8. Effects of dietary choline, betaine, and L-carnitine on the generation of trimethylamine-N-oxide in healthy mice. Yu ZL; Zhang LY; Jiang XM; Xue CH; Chi N; Zhang TT; Wang YM J Food Sci; 2020 Jul; 85(7):2207-2215. PubMed ID: 32572979 [TBL] [Abstract][Full Text] [Related]
9. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery. Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744 [TBL] [Abstract][Full Text] [Related]
10. Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery. Wu WK; Panyod S; Liu PY; Chen CC; Kao HL; Chuang HL; Chen YH; Zou HB; Kuo HC; Kuo CH; Liao BY; Chiu THT; Chung CH; Lin AY; Lee YC; Tang SL; Wang JT; Wu YW; Hsu CC; Sheen LY; Orekhov AN; Wu MS Microbiome; 2020 Nov; 8(1):162. PubMed ID: 33213511 [TBL] [Abstract][Full Text] [Related]
11. An in vitro exploratory study of dietary strategies based on polyphenol-rich beverages, fruit juices and oils to control trimethylamine production in the colon. Bresciani L; Dall'Asta M; Favari C; Calani L; Del Rio D; Brighenti F Food Funct; 2018 Dec; 9(12):6470-6483. PubMed ID: 30465688 [TBL] [Abstract][Full Text] [Related]
12. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. Romano KA; Vivas EI; Amador-Noguez D; Rey FE mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704 [TBL] [Abstract][Full Text] [Related]
13. Methodological considerations for the identification of choline and carnitine-degrading bacteria in the gut. Jameson E; Quareshy M; Chen Y Methods; 2018 Oct; 149():42-48. PubMed ID: 29684641 [TBL] [Abstract][Full Text] [Related]
14. Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota. Hoyles L; Jiménez-Pranteda ML; Chilloux J; Brial F; Myridakis A; Aranias T; Magnan C; Gibson GR; Sanderson JD; Nicholson JK; Gauguier D; McCartney AL; Dumas ME Microbiome; 2018 Apr; 6(1):73. PubMed ID: 29678198 [TBL] [Abstract][Full Text] [Related]
15. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk. Zhu W; Buffa JA; Wang Z; Warrier M; Schugar R; Shih DM; Gupta N; Gregory JC; Org E; Fu X; Li L; DiDonato JA; Lusis AJ; Brown JM; Hazen SL J Thromb Haemost; 2018 Sep; 16(9):1857-1872. PubMed ID: 29981269 [TBL] [Abstract][Full Text] [Related]